[Imidafenacin (Uritos) is contraindicated in the following patients]: Patients with urinary retention. [Symptoms may be aggravated due to inhibition of bladder contraction during urination caused by the anticholinergic effect of this product.]
Patients with occluded pyloric region/duodenum/intestine or paralytic ileus. [Symptoms may be aggravated due to inhibition of contraction and motility of gastrointestinal smooth muscles caused by the anticholinergic effect of this product.]
Patients with decreased gastrointestinal motility. [Symptoms may be aggravated due to inhibition of contraction and motility of gastrointestinal smooth muscles caused by the anticholinergic effect of this product.]
Patients with angle closure glaucoma. [Symptoms may be aggravated due to an increase in intraocular pressure caused by the anticholinergic effect of this product.]
Patients with myasthenia gravis. [Symptoms may be aggravated due to a decrease in muscle tone caused by the anticholinergic effect of this product.]
Patients with severe heart disease. [Symptoms may be aggravated since abnormal electrocardiographic findings including extrasystoles have been reported.]
Patients with a history of hypersensitivity to any of the components of this product.
Other Services
Country
Account